Efficacy And Safety Study Of Atorvastatin Versus Simvastatin In Type 2 Diabetic Subjects With Hypercholesterolemia

PHASE4CompletedINTERVENTIONAL
Enrollment

383

Participants

Timeline

Start Date

January 31, 2004

Study Completion Date

April 30, 2007

Conditions
Hypercholesterolemia
Interventions
DRUG

Atorvastatin

DRUG

Simvastatin

Trial Locations (35)

10043

Pfizer Investigational Site, Orbassano

10154

Pfizer Investigational Site, Torino

14100

Pfizer Investigational Site, Asti

16132

Pfizer Investigational Site, Genova

20142

Pfizer Investigational Site, Milan

20145

Pfizer Investigational Site, Milan

20157

Pfizer Investigational Site, Milan

27100

Pfizer Investigational Site, Pavia

30174

Pfizer Investigational Site, Mestre

33100

Pfizer Investigational Site, Udine

43100

Pfizer Investigational Site, Parma

44100

Pfizer Investigational Site, Ferrara

47900

Pfizer Investigational Site, Rimini

56124

Pfizer Investigational Site, Pisa

60100

Pfizer Investigational Site, Ancona

63039

Pfizer Investigational Site, S. Benedetto DEL Tronto

Pfizer Investigational Site, S. Benedetto Del Tronto (AP)

70124

Pfizer Investigational Site, Bari

73043

Pfizer Investigational Site, Casarano

80100

Pfizer Investigational Site, Napoli

80131

Pfizer Investigational Site, Napoli

85100

Pfizer Investigational Site, Potenza

86100

Pfizer Investigational Site, Campobasso

88100

Pfizer Investigational Site, Catanzaro

90127

Pfizer Investigational Site, Palermo

95124

Pfizer Investigational Site, Catania

95126

Pfizer Investigational Site, Catania

98158

Pfizer Investigational Site, Messina

Unknown

Pfizer Investigational Site, S.Pietro Vernotico

09134

Pfizer Investigational Site, Cagliari

06100

Pfizer Investigational Site, Perugia

00155

Pfizer Investigational Site, Roma

00161

Pfizer Investigational Site, Roma

00163

Pfizer Investigational Site, Roma

00168

Pfizer Investigational Site, Roma

All Listed Sponsors
lead

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

INDUSTRY

NCT00141141 - Efficacy And Safety Study Of Atorvastatin Versus Simvastatin In Type 2 Diabetic Subjects With Hypercholesterolemia | Biotech Hunter | Biotech Hunter